Cargando…
Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review
SIMPLE SUMMARY: Porphyria is a metabolic condition which leads to reduced heme production. While it involves multiple organs systems, porphyria affecting the liver can lead to elevations in hepatic enzymes, progressive fibrosis, cirrhosis and eventually malignancy. Our study looked at the prevalence...
Autores principales: | Ramai, Daryl, Deliwala, Smit S., Chandan, Saurabh, Lester, Janice, Singh, Jameel, Samanta, Jayanta, di Nunzio, Sara, Perversi, Fabio, Cappellini, Francesca, Shah, Aashni, Ghidini, Michele, Sacco, Rodolfo, Facciorusso, Antonio, Giacomelli, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221430/ https://www.ncbi.nlm.nih.gov/pubmed/35740611 http://dx.doi.org/10.3390/cancers14122947 |
Ejemplares similares
-
Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
por: Ramai, Daryl, et al.
Publicado: (2023) -
Hospital Frailty Risk Score Is Independently Associated with Mortality and Encephalopathy in Hospitalized Patients with Hepatocellular Carcinoma
por: Ramai, Daryl, et al.
Publicado: (2021) -
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021) -
EUS–guided therapies for primary and secondary prophylaxis in gastric varices—An updated systematic review and meta-analysis
por: Chandan, Saurabh, et al.
Publicado: (2023) -
Cholangiocarcinoma in the Era of Immunotherapy
por: Manthopoulou, Eleni, et al.
Publicado: (2023)